News

Graphic that includes two images of a lung adenocarcinoma tissue sample, the input multiplex immunofluorescence image and a multiplex image analysis markup image, and a histogram of membrane intensity distribution under different analysis conditions.

Updated HALO® Multiplex IHC and Highplex FL Modules Deliver Greater Analysis Flexibility and Deeper Cellular Insight

Albuquerque, NM, November 19, 2026 – Indica Labs, the trusted global leader in AI-powered digital pathology, today announces the release of the latest versions of its HALO Multiplex IHC and Highplex FL modules for multiplex image analysis of whole slide pathology images.

Updated HALO® Multiplex IHC and Highplex FL Modules Deliver Greater Analysis Flexibility and Deeper Cellular Insight Read More »

Graphic that includes two images of a lung adenocarcinoma tissue sample, the input multiplex immunofluorescence image and a multiplex image analysis markup image, and a histogram of membrane intensity distribution under different analysis conditions.

Announcing HALO® Multiplex IHC and Highplex FL Modules Supporting New Features to Assist Single-Cell-Level Analysis

In this blog post, you can learn about the variety of new features added to the HALO Multiplex IHC and Highplex FL modules, where to find the user guides, and when to expect to upgrade.

Announcing HALO® Multiplex IHC and Highplex FL Modules Supporting New Features to Assist Single-Cell-Level Analysis Read More »

NeoGenomics and Indica Labs expand on their digital pathology partnership, designed to support high-volume clinical operations through a cloud-based deployment while providing a scalable foundation for future AI and companion diagnostic (CDx) initiatives.

Indica Labs and NeoGenomics Expand AI Leadership Through Enterprise Digital Pathology Partnership

ALBUQUERQUE, N.M, October 15, 2026 — Indica Labs, the trusted global leader in AI-powered digital pathology, today announced a significant expansion of its strategic partnership with NeoGenomics, a leading provider of oncology diagnostic solutions that enable precision medicine. The expanded collaboration modernizes NeoGenomics enterprise digital pathology infrastructure, accelerates AI adoption across clinical operations and biomarker analysis, and establishes a joint development framework for the next generation of companion diagnostic (CDx) solutions.

Indica Labs and NeoGenomics Expand AI Leadership Through Enterprise Digital Pathology Partnership Read More »

Voicebrook's integration with Indica’s HALO AP platform brings speech-driven command and control to digital slide review and pulls HALO Clinical AI biomarker results directly into CAP cancer checklists, eliminating manual re-entry between image analysis and the pathology report.

Voicebrook Announces Digital Pathology Integration with Indica Labs, Delivering Automated AI Biomarker Reporting and Hands-Free Navigation

Roslyn Heights, NY and Albuquerque, NM, September 22, 2026 – Voicebrook, the leader in pathology workflow automation, driving reporting end to end, today announced a new integration partnership with Indica Labs, the trusted global leader in AI-powered digital pathology . The integration connects Voicebrook’s VoiceOver PRO reporting workflow to the Indica Labs HALO AP platform, giving pathologists hands-free control of digital slide review while allowing HALO Clinical AI-generated biomarker results to flow automatically into the appropriate CAP cancer protocol checklist.

Voicebrook Announces Digital Pathology Integration with Indica Labs, Delivering Automated AI Biomarker Reporting and Hands-Free Navigation Read More »

The image shows both company logos of Indica Labs and Source LDPath showcasing the partnership. Since deploying HALO AP® at its Nottingham headquarters, Source BioScience has processed approximately 78,000 cases and 278,000 slides in under nine months with a national rollout now underway that will significantly expand digital pathology capacity across the UK’s outsourced histopathology market.

Source BioScience Selects Indica Labs’ HALO AP® as the Digital Pathology Platform Powering the Future of NHS Outsourcing in the United Kingdom

Albuquerque, NM, and Nottingham, September 8, 2026 – Indica Labs, the trusted global leader in AI-powered digital pathology and Source Bioscience, the United Kingdom’s leading provider of histopathology services, today announced Source Bioscience’s successful expansion of its digital pathology operation powered by HALO AP®. Since going live at Nottingham headquarters in October 2025, the organization has demonstrated how an interoperable, scanner-agnostic enterprise platform can eliminate one of the greatest barriers to large-scale digital pathology outsourcing while enabling rapid laboratory growth.

Source BioScience Selects Indica Labs’ HALO AP® as the Digital Pathology Platform Powering the Future of NHS Outsourcing in the United Kingdom Read More »

Scroll to Top